Early recovery of frontal EEG slow wave activity during propofol sedation predicts outcome after cardiac arrest.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
08 2021
Historique:
received: 03 02 2021
revised: 30 04 2021
accepted: 30 05 2021
pubmed: 11 6 2021
medline: 13 8 2021
entrez: 10 6 2021
Statut: ppublish

Résumé

EEG slow wave activity (SWA) has shown prognostic potential in post-resuscitation care. In this prospective study, we investigated the accuracy of continuously measured early SWA for prediction of the outcome in comatose cardiac arrest (CA) survivors. We recorded EEG with a disposable self-adhesive frontal electrode and wireless device continuously starting from ICU admission until 48 h from return of spontaneous circulation (ROSC) in comatose CA survivors sedated with propofol. We determined SWA by offline calculation of C-Trend® Index describing SWA as a score ranging from 0 to 100. The functional outcome was defined based on Cerebral Performance Category (CPC) at 6 months after the CA to either good (CPC 1-2) or poor (CPC 3-5). Outcome at six months was good in 67 of the 93 patients. During the first 12 h after ROSC, the median C-Trend Index value was 38.8 (interquartile range 28.0-56.1) in patients with good outcome and 6.49 (3.01-18.2) in those with poor outcome showing significant difference (p < 0.001) at every hour between the groups. The index values of the first 12 h predicted poor outcome with an area under curve of 0.86 (95% CI 0.61-0.99). With a cutoff value of 20, the sensitivity was 83.3% (69.6%-92.3%) and specificity 94.7% (83.4%-99.7%) for categorization of outcome. EEG SWA measured with C-Trend Index during propofol sedation offers a promising practical approach for early bedside evaluation of recovery of brain function and prediction of outcome after CA.

Identifiants

pubmed: 34111496
pii: S0300-9572(21)00216-1
doi: 10.1016/j.resuscitation.2021.05.032
pii:
doi:

Substances chimiques

Propofol YI7VU623SF

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

170-176

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Jukka Kortelainen (J)

Physiological Signal Analysis Team, Center for Machine Vision and Signal Analysis, MRC Oulu, University of Oulu, Oulu, Finland; Cerenion Oy, Oulu, Finland. Electronic address: jukka.kortelainen@oulu.fi.

Tero Ala-Kokko (T)

Research Group of Surgery, Anaesthesiology and Intensive Care, Medical Faculty, University of Oulu, Oulu, Finland; Division of Intensive Care Medicine, MRC Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.

Marjaana Tiainen (M)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Daniel Strbian (D)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Kirsi Rantanen (K)

Department of Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Jouko Laurila (J)

Research Group of Surgery, Anaesthesiology and Intensive Care, Medical Faculty, University of Oulu, Oulu, Finland; Division of Intensive Care Medicine, MRC Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.

Juha Koskenkari (J)

Research Group of Surgery, Anaesthesiology and Intensive Care, Medical Faculty, University of Oulu, Oulu, Finland; Division of Intensive Care Medicine, MRC Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.

Mika Kallio (M)

Department of Clinical Neurophysiology, MRC Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland; Research Unit of Medical Imaging, Physics and Technology, University of Oulu, Finland.

Jussi Toppila (J)

Department of Clinical Neurophysiology, HUS Diagnostics Center, Helsinki University Hospital, Helsinki, Finland; Department of Clinical Neurosciences (Neurophysiology), University of Helsinki, Helsinki, Finland.

Eero Väyrynen (E)

Cerenion Oy, Oulu, Finland.

Markus B Skrifvars (MB)

Department of Emergency Care and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Johanna Hästbacka (J)

Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH